HISAMITSU PHARMACEUTICAL CO INC financial statements, including revenue, expenses, and profit
The total revenue of HPX for the last quarter is 225.95 M EUR, and it's 7.95% lower compared to the previous quarter. The net income of Q3 24 is 28.80 M EUR.